Clinical Study Results
Research Sponsor: MedImmune, LLC
Drug Studied: MEDI5884
Study Title: A study to learn how MEDI5884 affects cholesterol
levels in healthy participants, and about the safety
of MEDI5884
Thank you!
Thank you to the participants who took part in the clinical study for the study drug
MEDI5884. MedImmune, LLC, a member of the AstraZeneca group, sponsored
this study and thinks it is important to share the results. An independent non-profit
organization called CISCRP helped prepare this summary of the study results.
If you participated in the study and have questions about the results, please speak
with the doctor or staff at your study site.
What is happening with the study now?
The study started in January 2017 and ended in August 2018. The study included
64 participants in the United States.
The sponsor reviewed the data collected when the study ended and created a
report of the results. This is a summary of that report.
1